Cite
MLA Citation
Thomas Danne et al.. “Efficacy and safety of adding sotagliflozin, a dual sodium‐glucose co‐transporter (SGLT)1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline body mass index ≥ 27 kg/m2.” Diabetes, obesity & metabolism, vol. 23, no. 3, 2021, pp. 854–860. http://access.bl.uk/ark:/81055/vdc_100122905427.0x00001c